Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-16-001569
Filing Date
2016-01-15
Accepted
2016-01-15 15:04:48
Documents
2
Period of Report
2016-01-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1563
2 durrantpoa.htm EX-24 7185
  Complete submission text file 0001123292-16-001569.txt   10090
Mailing Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 90, FAIRMOUNT ROAD WEST CALIFON NJ 07830-3330
Business Address
Durrant Cameron (Reporting) CIK: 0001421882 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35798 | Film No.: 161345120